CONHealthcare · Medical Care FacilitiesThe 11 Wall Street analysts covering Concentra Group Holdings Parent, Inc. hold a median 12-month price target of $42 — -4.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 93 of 100 as at 4 Nov 2026 — among the strongest tenth. The factors read stronger than the Street's target implies. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores Concentra Group Holdings Parent, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Momentum (99): The shares have been drifting up relative to others.
Accruals (58): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Size (22): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on CON, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits −4.7% from it.
Of the 20 most recent actions, 5 moved their price target up and 0 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 20 Oct 2026 | Stephens & Co. | Initiates | Overweight | $45 |
| 16 Oct 2026 | Jefferies | Initiates | Buy | $47 |
| 10 Sept 2026 | JP Morgan | Maintains | Overweight | $34 → $43 |
| 10 Sept 2026 | JP Morgan | Maintains | Overweight | — |
| 11 Aug 2026 | Wells Fargo | Maintains | Overweight | $28 → $40 |
| 11 Aug 2026 | Wells Fargo | Maintains | Overweight | — |
| 10 Aug 2026 | RBC Capital | Maintains | Outperform | — |
| 10 Aug 2026 | RBC Capital | Maintains | Outperform | $36 → $42 |
| 10 Aug 2026 | Truist Securities | Maintains | Buy | — |
| 10 Aug 2026 | Truist Securities | Maintains | Buy | $37 → $42 |
| 14 July 2026 | Truist Securities | Maintains | Buy | — |
| 14 July 2026 | Truist Securities | Maintains | Buy | $31 → $37 |
| 1 July 2026 | William Blair | Initiates | Outperform | — |
| 1 July 2026 | William Blair | Initiates | Outperform | — |
| 5 June 2026 | Goldman Sachs | Initiates | Buy | — |
| 11 May 2026 | Truist Securities | Reiterates | Buy | — |
| 5 Mar 2026 | Wells Fargo | Maintains | Overweight | — |
| 2 Feb 2026 | RBC Capital | Maintains | Outperform | — |
| 18 Sept 2025 | JP Morgan | Assumes | Overweight | $31 |
| 19 Mar 2025 | JP Morgan | Maintains | Overweight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
CON appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, Concentra Group Holdings Parent, Inc. returned +127.2% against +14.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 27% of US stocks
Cheaper than 46% of US stocks
Cheaper than 7% of US stocks
Cheaper than 22% of US stocks
Higher than 53% of US stocks
Higher than 73% of US stocks
Higher than 36% of US stocks
Higher than 78% of US stocks
Higher than 67% of US stocks
Higher than 93% of US stocks
Higher than 88% of US stocks
Higher than 66% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Concentra Group Holdings Parent, Inc. has a market value of $5.1B and an enterprise value of $7.1B.
Revenue in the twelve months to 30 June 2026: $2.3B. The latest quarter grew 10.0% year on year.
Net income over the same four quarters: $205.6M, a 9.0% net margin.
Diluted earnings per share, trailing twelve months: $1.55.
Free cash flow in the twelve months to 30 June 2026: $267.4M.
Concentra Group Holdings Parent, Inc. spent $32.1M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 27.9×; forward P/E: 23.5× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.58%, paying out 16% of earnings.
Concentra Group Holdings Parent, Inc. employs 9,967 people — $230K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Concentra Group Holdings Parent, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Zacks Investment Research compares Concentra Group and Medpace as medical services stocks and asks which presents the better value opportunity. The excerpt does not state the comparison’s conclusion.
Why it matters — A CON watcher may find the item relevant because it frames Concentra alongside Medpace in a value comparison, but the excerpt provides no outcome.
Zacks Investment Research compares Concentra Group (CON) and Centene (CNC) with their sector’s performance so far this year. The excerpt does not provide performance results.
Why it matters — The comparison is relevant to CON watchers assessing the stock’s year-to-date performance relative to its sector, but the excerpt gives no outcome.
Concentra (CON) has reached a 52-week high. Zacks Investment Research examines the company’s fundamentals for clues about whether gains could continue.
Why it matters — The article focuses on CON’s recent share-price high and the fundamentals investors may consider when assessing the company.
Concentra is expanding its Washington, D.C.-area network with a new medical center in Arlington, Virginia. The Reagan Airport location brings its presence in the region to more than 15 medical centers.
Why it matters — The opening expands Concentra’s occupational health service access for employers and employees across Northern Virginia.
Zacks Investment Research compares Concentra Group (CON) and Medpace (MEDP) for investors seeking value among medical services stocks, asking which may offer better value.
Why it matters — The item directly compares CON with MEDP from a value-investing perspective, which may interest investors following CON.
The 11 Wall Street analysts covering Concentra Group Holdings Parent, Inc. have a median 12-month price target of $42, with estimates ranging from $40 to $47. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 11 analysts covering Concentra Group Holdings Parent, Inc., 11 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Concentra Group Holdings Parent, Inc. 93 out of 100 across roughly 4,600 US stocks as at 4 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 4 Nov 2026, Concentra Group Holdings Parent, Inc. ranks 93 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (99 of 100).
No one can know that. What the data says: the median 12-month target from 11 analysts implies -4.7% from the last close, and Ticker Nerd's factor model ranks Concentra Group Holdings Parent, Inc. 93 out of 100 as at 4 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Concentra Group Holdings Parent, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CON are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $40 to $47 over the next 12 months.
Concentra Group Holdings Parent, Inc. returned +127.2% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
Concentra Group Holdings Parent, Inc. is a healthcare services company focused on occupational health in the United States.
The most recent item we track (Zacks Investment Research, 2 Nov 2026): "CON vs. MEDP: Which Stock Is the Better Value Option?". Zacks Investment Research compares Concentra Group and Medpace as medical services stocks and asks which presents the better value opportunity. The excerpt does not state the comparison’s conclusion.
Concentra Group Holdings Parent, Inc. is a healthcare services company focused on occupational health in the United States. It provides workplace-oriented medical care through occupational health centers, onsite health clinics, and complementary service lines designed to support employers and working populations. Its offerings include workers’ compensation injury care, urgent care, clinical testing, preventive care, employer-sponsored primary care, telemedicine for work-related injuries and illnesses, pharmacy services, and medical compliance administration. Concentra Group Holdings Parent, Inc. serves businesses across industries that rely on employee health and safety programs, helping manage care delivered at employer worksites and through its network of health centers. The company is headquartered in Addison, Texas.
CEO Mr. William Keith Newton · 9,967 employees · United States · https://www.concentra.com
